Elbit Imaging (EI) Ltd.

www.elbitimaging.com (under construction)

Holding Company
Public Company

(NASDAQ GS: EMIT)

Tech Verticals Preferences

Enterprise Applications, Internet Applications, Medical Devices, MedTech, Telecom Applications, VoIP

General Data

Established	1996
Current Active Portfolio Companies:	1
Reg. Number:	abCDe

DESCRIPTION

Elbit Imaging is an Israel-based holding company. It operates in the fields of Commercial and Entertainment Centers, engaged in the initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector; United States Real Property, investing in commercial real property in the United States; Hotels, engaged in the management and operation of hotels; Medical Industries, engaged in research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; Residential Projects, engaged in the initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, and Fashion Apparel, engaged in the Distribution and marketing of fashion apparel and accessories.

REMARKS

Date	Remark
01/11/2010	Elbit Medical (constituted of Elbit Image's shares in InSightec and Gamida Cell) underwent a reverse merger into Enter Holdings 1 Ltd. (TASE: ENHD).

CONTACT INFO

Expand / Collapse All

Main Address: Bnei Brak, Israel

Address	5 Kineret St., BSR Tower 3
City	Bnei Brak
Country	Israel
Zip	5112301

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Ron Hadassi	Chairman
Mr. Doron Moshe	Acting CEO
Ms. Rivka Steiner	CFO
Mr. Amit Shiff	Deputy General Counsel & VP, Technology Investments
Mr. Oren Kolton	VP & India and Greece Country Director
Mr. Ifat Avidan	Executive Assistant to CEO & VP Public Relations
Mr. Alon Bachar	Director
Mr. Nadav Balvani	Director
Mr. Eliezer Brand	Director
Mr. Shlomi Kelsi	Director
Mr. Moshe Lion	Director
Mr. Shmuel Perets	Director
Mr. Zvi Tropp	External Director
Ms. Elina Frenkel-Ronen	External Director

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Aug. 24, 2006	Third Public Offering	TASE	abCDe	abCDe
Nov. 27, 1996	Second Public Offering	NASDAQ GS	abCDe	abCDe
Aug. 01, 1996	Dual Listing	TASE	abCDe	abCDe
Aug. 01, 1996	IPO	NASDAQ GS	abCDe	abCDe	08/2019: Delisted From Nasdaq

	FINANCIAL ROUNDS

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

PIPE

Feb. 27, 2014

Revenue Growth

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Private Equity Fund	abCDe	Bonds purchased through the market in 2012/2013 turned into shares following a debt agreement. Now holds 19.76% of the company.
abC Defghij	Hedge Fund	abCDe	Bonds purchased through the market in 2012/2013 turned into shares following a debt agreement. Now holds 14.3% of the company.

Investment Data

Capital Remarks

Total amount invested until 2005: $90m 06/2009: Raised $7.6m in bonds.

Preferences

Type of Financing	Equity
Stage Preferences	Initial Revenues,R&D,Revenue Growth,Seed
Phase Preferences	FDA Approved

SECTOR SEGMENTATION (By Number Of Companies)

Medical Devices

100%

	PORTFOLIO COMPANIES

Current Portfolio Companies (1)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

InSightec

$Insightec is a global healthcare company creating the next generation of patient care by realizing the therapeutic power of focused ultrasound. The company's Exablate Prime platform focuses sound waves, safely guided by MRI, to provide tremor treatment to patients with medication-refractory essential tremor and Parkinson's disease. Research for future applications in the neuroscience space is underway in partnership with leading academic and medical institutions.$

Fifth Round	01/11/2017	N/A	$150m	02/2020: Sold most of its shares to Koch for $103.4m. Now holds 3.7%.
Fourth Round - Extended	10/01/2016	N/A	$22m
Second Round - Extended	18/03/2009	$7.5m	$7.5m	Additional $7.5m will be invested. Elbit Medical (constituted of Elbit Image's shares in InSightec and Gamida Cell) underwent a reverse merger into Enter Holdings 1 Ltd. (TASE: ENHD).
Second Round	29/11/2007	$19.8m	$30m	Through Elbit Medical
First Round - Extended	09/08/2006	$9.8m	$15m
First Round - Extended	28/09/2004	$7.5m	$21m
First Round	01/05/1999	$20m	$25m

Exits (7)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	Acquired	03/09/2012	abCDe
abC Defghij	Acquired	27/03/2024	abCDe
abC Defghij	IPO	26/10/2018	abCDe	Including Green Shoe options ($3m); 05/2024: Delested from NASDQ.
abC Defghij	Acquired	01/07/2018	abCDe
abC Defghij	Holdings Sold		abCDe
abC Defghij	Acquired	25/05/2011	abCDe
abC Defghij	Acquired	17/08/2005	abCDe	Shares deal.